MedTrace Logo

Cardiometabolic Disease Risk Factors in Cameroon

NCT06957548 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-26

No results posted yet for this study

Summary

Cardiometabolic diseases (CMDs) are a major public health concern in sub-Saharan Africa, including Cameroon. Studies have shown a significant increase in the prevalence of hypertension, diabetes, and obesity in recent years. However, access to timely diagnosis and treatment remains limited, particularly in rural areas. Community-based screening programs have been shown to be effective in identifying individuals with undiagnosed CMD risk factors and promoting early intervention. By leveraging the strengths of community-based approaches, the URBACAM-D study aims to address the growing burden of CMDs in urban Cameroon.

Conditions

  • Cardiac Disease
  • Metabolic Disease

Interventions

DIAGNOSTIC_TEST

Cardiometabolic disease

Cardiometabolic disease screening

Sponsors & Collaborators

Principal Investigators

  • Dimitri Tito, DO · Johns Hopkins University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-09
Primary Completion
2025-10-12
Completion
2027-02-12

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06957548 on ClinicalTrials.gov